We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$17.9B
AUM Growth
-$735M
Cap. Flow
-$1.5B
Cap. Flow %
-8.4%
Top 10 Hldgs %
36.95%
Holding
2,950
New
767
Increased
679
Reduced
655
Closed
682

Sector Composition

Rank Sector Weight
1 Technology 3.58%
2 Consumer Discretionary 2.65%
3 Financials 2.57%
4 Healthcare 2.39%
5 Industrials 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMA
2076
DELISTED
Comerica
CMA
$88K ﹤0.01%
968
-23,318
-96% -$2.23M
BWP
2077
PUT
DELISTED
Boardwalk Pipeline Partners
BWP
$87K ﹤0.01%
+7,500
New +$79.2K
GSK icon
2078
GSK
GSK
$103B
$84K ﹤0.01%
+1,672
New +$84.2K
FTD
2079
DELISTED
FTD Companies, Inc. Common Stock
FTD
$82K ﹤0.01%
+17,600
New +$98.5K
HSIC icon
2080
PUT
Henry Schein
HSIC
$9.74B
$80K ﹤0.01%
+1,403
New +$79.1K
NE
2081
DELISTED
Noble Corporation
NE
$78K ﹤0.01%
+12,357
New +$63.3K
HTZ
2082
DELISTED
Hertz Global Holdings, Inc.
HTZ
$77K ﹤0.01%
5,777
+4,697
+435% +$76.1K
MDLZ icon
2083
Mondelez International
MDLZ
$77.7B
$75K ﹤0.01%
1,836
-55,656
-97% -$2.24M
AUY
2084
DELISTED
Yamana Gold, Inc.
AUY
$75K ﹤0.01%
+25,700
New +$74.7K
KMB icon
2085
PUT
Kimberly-Clark
KMB
$36.4B
$74K ﹤0.01%
700
-600
-46% -$62.3K
BNED icon
2086
Barnes & Noble Education
BNED
$412M
$72K ﹤0.01%
+128
New +$85.6K
VRDN icon
2087
Viridian Therapeutics
VRDN
$2.13B
$72K ﹤0.01%
+751
New +$79.4K
ARDX icon
2088
Ardelyx
ARDX
$1.24B
$68K ﹤0.01%
+18,300
New +$84.9K
AAC
2089
DELISTED
AAC Holdings
AAC
$68K ﹤0.01%
+7,242
New +$79.1K
EGIO
2090
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
$67K ﹤0.01%
+375
New +$72.7K
ANW
2091
DELISTED
Aegean Marine Petroleum Network
ANW
$67K ﹤0.01%
+101,489
New +$225K
EVC icon
2092
Entravision Communication
EVC
$983M
$66K ﹤0.01%
+13,154
New +$60.6K
STZ icon
2093
CALL
Constellation Brands
STZ
$22.2B
$66K ﹤0.01%
300
-62,700
-100% -$14.2M
STZ icon
2094
PUT
Constellation Brands
STZ
$22.2B
$66K ﹤0.01%
+300
New +$67.8K
LCTX icon
2095
Lineage Cell Therapeutics
LCTX
$257M
$65K ﹤0.01%
+36,030
New +$72.5K
SB icon
2096
Safe Bulkers
SB
$781M
$63K ﹤0.01%
+18,605
New +$61.7K
TGTX icon
2097
TG Therapeutics
TGTX
$8.58B
$63K ﹤0.01%
+4,800
New +$66K
EOG icon
2098
PUT
EOG Resources
EOG
$78B
$62K ﹤0.01%
500
-7,500
-94% -$871K
LMT icon
2099
PUT
Lockheed Martin
LMT
$134B
$59K ﹤0.01%
200
-129,300
-100% -$41.7M
CTMX icon
2100
CytomX Therapeutics
CTMX
$705M
$58K ﹤0.01%
2,551
-42,663
-94% -$1.09M

Similar funds

Jefferies Group's Q2 2018 Portfolio in Review

As of Q2 2018, Jefferies Group held 2,950 positions worth $17.9B, down 4% from $18.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jefferies Group withdrew a net $1.5B in Q2 2018, closing 682 positions and reducing 655 holdings. Its most notable exit was Time Warner Inc, an estimated $300M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jefferies Group opened a new position in Tiffany & Co. worth $59.5M.

  • Jefferies Group's largest Q2 2018 buy was Tiffany & Co.: 452,024 shares worth $59.5M.
  • Jefferies Group added most to Bank of America in Q2 2018, an estimated $167M increase.
  • Jefferies Group's biggest Q2 2018 reduction was Avis, cutting an estimated $287M.
  • Jefferies Group fully exited Time Warner Inc in Q2 2018, selling an estimated $300M.
  • Jefferies Group's ten largest holdings make up 37% of its $17.9B portfolio in Q2 2018.
  • Jefferies Group opened 767 new positions and closed 682 in Q2 2018.
  • Jefferies Group's portfolio value fell 4% quarter-over-quarter to $17.9B.

Based on Jefferies Group's 13F filing for Q2 2018, filed 14 Aug 2018.